The possibility of altered B-adrenergic receptors and/or adenyl cyclase activity in fibroblasts from patients with cystic fibrosis (CF) has been raised by several groups of investigators. Buchwald (1) reported a greater increase in CAMP' after isoproterenol stimulation in CF than in normal fibroblasts and this was confirmed by Roscher et al. (2) for CF and normal fibroblasts in fresh medium. Furthermore, CF fibroblasts were shown to be more resistant to the cytotoxic effects of exogenous dibutyrl CAMP or isoproterenol than were normal fibroblasts (3). However, Buchwald and Mapelson (4) and Davis et al. (5) could not reproduce these differences in response to isoproterenol between CF and normal cultured skin fibroblasts. The CAMP response of fibroblasts to isoproterenol is known to be highly sensitive to time and cell density in culture (6) and the negative reports on differences between CF and normal fibroblasts (4, 5) noted high day-to-day variability. We have studied the response to metaproterenol (a congener of isoproterenol) of pairs of CF and normal fibroblast strains compared blind on the same day and found greater responses in the CF strains. We have sought the basis for this difference by measuring B-adrenergic receptors and find increased binding capacity for a P-adrenergic antagonist.
METHODS
Fibroblasts were obtained either from the Human Genetics Mutant Cell Repository or from patients at the University of Michigan Hospital. The cell lines were grown as monolayers at 37°C in 5% CO, in polystyrene tissue culture flasks (obtained from Corning). Eagle's basal medium with MARKOVAC, ERICKSON, AND HIEBER Earle's salts was supplemented with 10% bobby calf serum, glutamine (30 mg/lOO ml), and 1% penicillin-streptomycin (all from Gibco). The cells were fed every 4 days and split approximately once a week. The cultured skin fibroblasts or amniocentesis-derived cells were treated with 10s5 M metaproterenol for 30 min. The medium was decanted leaving 0.5 ml and cells were rapidly (< 30 set) scraped with a rubber policeman.
Aliquots were immediately pipetted into centrifuge tubes positioned in a boiling water bath and heated at 97°C for 10 min. The tubes were cooled to 0°C and centrifuged at 800g for 15 min and aliquots of the supernatant fluid were assayed for CAMP by the Gilman proteinbinding method (7) while the pellet was analyzed for protein by the method of Lowry et al. (8) . The cross-reactivity of the CAMP antiserum with cyclic GMP was < 0.00008%, as indicated in the technical information with the CAMP ['251]RIA kit (obtained from New England Nuclear).
To assay p-adrenergic receptors, the cells were prepared for assay by washing twice with 0.05 M Tris-buffered saline, pH 7.4, and scraping with a rubber policeman. (Trypsin cannot be used because of the sensitivity of the P-adrenergic receptor to proteolytic degradation.) The cell suspension was then centrifuged at 15Og and the pellet resuspended to approximately 30 mg protein/ml. B-Adrenergic receptors were measured by a competitive binding assay with the potent P-adrenergic antagonist, [3H]dihydroalprenolol ([3H]DHA), essentially as described by Mukherjee and Lefkowitz (9) . The reaction was carried out in a total volume of 500 ~1, containing 400 ~1 cell suspension, 10 nM [3H]DHA, and either 10 PM (+-) propranolol or an equivalent amount of buffer. The assay was incubated for 10 min at 37°C and terminated by adding ice-cold Tris buffer and emptying the sample over a Whatman GF/C filter. The filters were washed thoroughly with buffer, dried, and counted in Instagel scintillation fluid. Protein content was determined by the method of Lowry et al. (8) . The specific binding, expressed as femtomoles per microgram protein, was calculated as the difference between total binding U3H]DHA only) and nonspecific binding ([3H]DHA and excess propranolol).
Plasma membranes were prepared from both the CF and normal fibroblasts, essentially as described by Kartner et al. (10). The cells were washed four times with 20 ml PBS and swollen with 25 ml of 1 mM NaHCO,, pH 7.4, for 1 min at room temperature. This hypotonic procedure was repeated and the cells were removed from the surface by manual shaking. The cell suspension was made 0.5 mM in EDTA, pH 7.4, and centrifuged for 20 min at 27,000g. The resulting pellet was resuspended in 5 ml of 10% (w/v) sucrose, layered on a discontinuous density gradient made up of 5 ml each of 30, 48, and 60% sucrose, and centrifuged at 76,000g for 2 hr in a SW27.1 rotor. Material banding at the interfaces was collected by aspiration, washed free of sucrose with 1 mM NaHCO,, pH 7.4, and centrifuged at 33,000g for 20 min. The fraction from the lo-30 interface was reported to contain plasma membranes (10) and this fraction was used in subsequent binding studies with both CF and normal lines.
RESULTS
We could consistently distinguish CF fibroblasts from normal lines when presented "blind" and as pairs. Under these conditions, CF fibroblasts showed 1.5 to 2.5fold greater induction of CAMP compared to normal fibroblasts after incubating the cells with 10e5 M metaproterenol, an analog of isoproterenol (Table 1 ). There was some overlap in the actual values from experiment to experiment, but within any one experiment there was always an increased induction of CAMP in the CF fibroblasts.
The time dependency of [3H]dihydroalprenolol (L3H]DHA) binding was performed in the presence and absence of a large excess of unlabeled propranolol and specific binding (total nonspecific) was found to be optimal after 10 min at 37°C. This time was used in all further experiments. Saturation experiments were performed using varying concentrations of suggests a difference in affinity between the CF and normal fibroblast P-adrenergic receptor but, due to assay variation, a Scatchard plot was not meaningful. Saturation studies using [3H]dihydroalprenolol on several tissues indicate the apparent equilibrium dissociation constant, K,,, to be 12-15 nM (11). We decided to continue to compare normal and CF fibroblast binding of [3H]DHA at 10 nM, this concentration being below the K,, since the normal receptor was saturated at this concentration and it has been the usual concentration used on a variety of cell types.
The mean "specific binding" for each CF and normal line as well as the cumulative means when assayed at the standardly used concentration of 10 nM, are shown in Table 2 . The threefold increase in CF cells is statistically significant by Student's t test (P < 0.001). Although we have found some overlap between CF and normal lines from one experiment to another, on a given day, the CF lines consistently showed increased P-adrenergic binding compared to normal cells. This is clearly shown by the CF/N ratio for each experiment, given in Table 3 , and is significant by the Wilcoxon rank sum test at P = 0.0011.
To confirm that we are dealing with cell surface receptors, P-adrenergic binding was measured on purified plasma membranes of CF and normal Note. P (w, 2 120) = 0.0011.
fibroblasts (Table 4 ). The membrane extracts from CF fibroblasts showed 7.15 ? 0.16 fmole/kg protein specifically bound while those from normal cells showed 2.7 -+ 0.65 fmole/pg protein. The lo-fold enrichment in padrenergic receptor in plasma membranes in both cases argues that the difference between CF and normal fibroblasts is not due to differences in compartmentalization of receptor.
DISCUSSION
There is increased stimulation of several types of autonomic nervous system glands such as the salivary gland in patients with CF (12, 13) . Evidence suggests that the altered exocrine secretions in these patients could be due to altered autonomic nervous system receptors in exocrine cells (14) . Cultured skin fibroblasts from patients with CF seem to exhibit this altered membrane property. We have found a greater induction of CAMP in CF fibroblasts than in normal fibroblast cells when they are incubated with B-adrenergic agonists. The CF fibroblasts, therefore, exhibit "supersensitivity" to B-adrenergic agonists with respect to normal fibroblast cells. The increased response could, a priori, be due to several factors, such as increased amount of B-adrenergic receptors, increased adenylate cyclase activity, or decreased PDE activity. The accompanying paper (15) shows that the high K,,, form of CAMP phosphodiesterase is increased, not decreased. Thus, we measured specific binding of the Badrenergic antagonist, [3H]dihydroalprenolol.
Although the saturation kinetics of binding were different in CF and normal fibroblasts, consistently more [3H]DHA was bound by CF than by normal fibroblasts when assayed at the standard concentration of 10 nM. This difference in binding was also found in the approximately lo-fold-enriched plasma membrane fraction. Buckwald and Riordan (16) did not find an increase in B-adrenergic receptors when studied on fibroblasts attached to plastic.
Although our, and some other, studies suggest increased B-adrenergic sensitivity, in viva studies and studies on lymphocytes have suggested decreased production of CAMP in cystic fibrosis: when corrected to cyclic GMP excretion, cystic fibrosis patients secreted less CAMP in urine than did normal controls (17) , were less sensitive to isoproterenolstimulated increases in blood pressure (IQ, and CF lymphocytes showed a decreased response of CAMP to isoproterenol stimulation (19) . In this regard, it may be that fibroblasts are more similar to the pupil of the eye which shows increased responses to both adrenergic and cholinergic agonists in viva (18) . The decreased responses of cardiac muscle and lymphocytes to isoproterenol might also reflect down regulation of Badrenergic receptors.
SUMMARY
We have found that CAMP is induced to a greater extent in cultured cystic fibrosis fibroblast cell lines than in normal lines using a p-adrenergic agonist. By using the potent B-antagonist, [3H]dihydroalprenolol in a competitive radioligand binding assay, we measured B-adrenergic specific binding on skin fibroblasts derived from cystic fibrosis patients and normal individuals.
The CF cells were found to have 0.73 ? 0.12 fmole/pg protein specifically bound, while normal cells showed 0.25 t 0.03 fmole/pg protein. Even though this difference is highly statistically significant, we found some overlap between the two cell types from one experiment to another. In any given experiment, however, the CF cells consistently showed increased B-adrenergic binding when compared to normal controls. Binding was measured on plasma membrane extracts from CF and normal fibroblasts. The CF lines continued to show increased specific binding compared to normal lines when partially purified plasma membranes were assayed. The B-adrenergic binding capacity of partially purified plasma membranes was significantly higher (10 times) than the values obtained with whole cells in both cases.
